Leiurus quinquestriatus venom (LQV)

Leiurus quinquestriatus venom, produced by the Deathstalker scorpion, is a complex pharmacological cocktail primarily composed of neurotoxic peptides that target various ion channels (StatPearls, 2023). The venom contains potent toxins such as chlorotoxin, which blocks small-conductance chloride channels, and various charybdotoxins and agitoxins that inhibit potassium channels (UniProt, 2024). These toxins induce a massive release of catecholamines, leading to a "sympathetic storm" characterized by hypertension, tachycardia, and potentially fatal pulmonary edema or cardiovascular collapse (PubMed, PMID: 11407513). While the whole venom is a medical threat, its individual components have been repurposed for biotechnology; for example, chlorotoxin has been utilized as a molecular "flashlight" to identify and target glioma cells in surgical oncology (NIH, 2021). Therapeutic management of envenomation involves the use of specific antivenoms, which consist of purified antibodies that neutralize the venom's toxic components in the bloodstream (Toxicon, 1995). Consequently, while the venom itself is not a traditional therapeutic target, it serves as both a source of drug leads and the primary target for neutralizing antivenom therapies.

Other names

Deathstalker scorpion venomYellow scorpion venomOmdurman scorpion venomLQ venom

The venom components bind to and modulate voltage-gated sodium channels and various potassium and chloride channels, leading to neuronal hyperexcitability and autonomic storm; antivenoms work by antibody-mediated sequestration and neutralization of these toxins.